1910 Publishes CANDID-CNS™, an AI Model That Unlocks Beyond Rule of 5 Chemical Space and Stereochemistry to Predict Blood–Brain Barrier Penetration

CANDID-CNS™ is the new state-of-the-art AI model for BBB penetration: it achieves 87% AUPRC on bRo5 small molecules compared to 56% by Pfizer’s ...

1910 Publishes CANDID-CNS(TM), an AI Model That Unlocks Beyond Rule of 5 Chemical Space and Stereochemistry to Predict Blood--Brain Barrier Penetration

BOSTON, Dec. 05, 2025 (GLOBE NEWSWIRE) -- 1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today announced that its CANDID-CNS (TM) AI model has been ...

Quantum technology moves from lab to life, but widespread use remains years away

Quantum technology is accelerating out of the lab and into the real world, and a new article argues that the field now stands ...

Evogene Ltd. (NASDAQ:EVGN) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call Transcript November 20, 2025 Evogene Ltd. beats earnings expectations. Reported EPS is $-0.31, ...